Adaptive Biotechnologies (ADPT)
(Delayed Data from NSDQ)
$3.39 USD
+0.08 (2.42%)
Updated Jun 4, 2024 04:00 PM ET
After-Market: $3.40 +0.01 (0.29%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth A Momentum D VGM
Brokerage Reports
Adaptive Biotechnologies Corporation [ADPT]
Reports for Purchase
Showing records 1 - 20 ( 37 total )
Company: Adaptive Biotechnologies Corporation
Industry: Medical - Biomedical and Genetics
Company: Adaptive Biotechnologies Corporation
Industry: Medical - Hospital
Company: Adaptive Biotechnologies Corporation
Industry: Medical - Hospital
Morning Meeting Notes
Provider: KEYBANC CAPITAL MARKETS
Company: Adaptive Biotechnologies Corporation
Industry: Medical - Hospital
Incrementally More Constructive Following Positive Comments from MPW
Provider: KEYBANC CAPITAL MARKETS
Analyst: GURDA J
Company: Adaptive Biotechnologies Corporation
Industry: Medical - Hospital
Healthcare Facilities and Services: ACA Repeal and Replace - Lots of Noise, but Risks Appear Modest
Provider: KEYBANC CAPITAL MARKETS
Analyst: GURDA J
Company: Adaptive Biotechnologies Corporation
Industry: Medical - Hospital
Morning Meeting Notes
Provider: KEYBANC CAPITAL MARKETS
Company: Adaptive Biotechnologies Corporation
Industry: Medical - Hospital
Very Disappointing Results, but 3Q Appears to Understate NT Earnings Potential
Provider: KEYBANC CAPITAL MARKETS
Analyst: GURDA J
Company: Adaptive Biotechnologies Corporation
Industry: Medical - Hospital
Company: Adaptive Biotechnologies Corporation
Industry: Medical - Hospital
Morning Meeting Notes
Provider: KEYBANC CAPITAL MARKETS
Company: Adaptive Biotechnologies Corporation
Industry: Medical - Hospital
Uncertainty Likely to Linger, but LT Opportunity Still Appears Attractive
Provider: KEYBANC CAPITAL MARKETS
Analyst: GURDA J
Company: Adaptive Biotechnologies Corporation
Industry: Medical - Hospital
Company: Adaptive Biotechnologies Corporation
Industry: Medical - Hospital
Company: Adaptive Biotechnologies Corporation
Industry: Medical - Hospital
LT Growth Opp?ty Appears Intact, but Guidance Looks Optimistic/Challenging
Provider: KEYBANC CAPITAL MARKETS
Analyst: GURDA J
Company: Adaptive Biotechnologies Corporation
Industry: Medical - Hospital
Research Summary
Provider: KEYBANC CAPITAL MARKETS
Company: Adaptive Biotechnologies Corporation
Industry: Medical - Hospital
Morning Meeting Notes
Provider: KEYBANC CAPITAL MARKETS
Company: Adaptive Biotechnologies Corporation
Industry: Medical - Hospital
Company: Adaptive Biotechnologies Corporation
Industry: Medical - Hospital
Morning Meeting Notes
Provider: KEYBANC CAPITAL MARKETS
Company: Adaptive Biotechnologies Corporation
Industry: Medical - Hospital
Company: Adaptive Biotechnologies Corporation
Industry: Medical - Hospital
Company: Adaptive Biotechnologies Corporation
Industry: Medical - Hospital
1Q Ahead, Guidance Unchanged as SS Volumes Turn Positive
Provider: KEYBANC CAPITAL MARKETS
Analyst: GURDA J